x
Track the entire patient journey over time with integrated multi-modal data, enabling proactive clinical decisions.
Molecular characterization and advanced
diagnostic profiling at point of detection.
Deep genomic profiling to guide targeted therapies & precision oncology decisions.
Multi-sample genomic profiling combining tissue, liquid biopsy, and matched normal DNA for comprehensive precision oncology insights.
Longitudinal molecular monitoring and recurrence tracking post-treatment.
Tumor residual monitoring via serial liquid biopsy for treatment response and relapse detection.
Hereditary risk profiling & pharmacogenomic
screening before cancer onset.
74-gene hereditary cancer panel covering 11+ syndromes (HBOC, Lynch, Li‑Fraumeni, Cowden, FAP, etc.) with MLPA for large rearrangements. Pre/post genetic counselling included.
Not just raw genomic data — clear, treatment-aligned insights
that fit directly into your clinical workflow.
Clinically relevant variant databases, Indian patient population
data, and pricing designed for Indian healthcare.
Tissue, liquid biopsy, and longitudinal insights unified in one ecosystem — no more fragmented testing.
Every recommendation is traceable to peer-reviewed literature and aligned with global treatment guidelines.
Reports designed for rapid scanning and confident decision-
making — not for lab scientists alone.
Understanding each cancer patient’s needs to deliver clinically meaningful, actionable genomic insights for clinicians.
Performance metrics based on internal quality monitoring and validated laboratory processes.
From advanced lab science to clinician-first reporting, every layer of our platform is built to improve treatment selection and patient outcomes.
| Capability | 1CELL.AI | Conventional Labs (India) |
|---|---|---|
| Core Focus | ✓Clinical actionability | Diagnostic data generation |
| Technology Depth | ✓Multi-modal (tissue + liquid + longitudinal) | Limited panels / standard testing |
| Report Design | ✓Clinician-first, structured for decisions | Basic, data-heavy reports |
| Therapy Relevance | ✓Contextualized for Indian patients & access | Limited therapy linkage |
| Turnaround Time & Access | ✓Faster, local processing | Faster but limited depth |
| Care Continuum | ✓Supports longitudinal monitoring & evolving decisions | One-time testing only |
Multi-omic approaches and advanced biomarker analysis to
uncover insights conventional
testing misses — especially in
complex or advanced cases.
Every report answers one
question: “What should I do
next?” — with prioritized
biomarkers, therapy-linked
insights, and structured summaries.
Faster turnaround, clear
communication, and seamless
integration into tumor boards —
from sample to decision without
friction.
Beyond one-time testing —
disease monitoring, resistance
tracking, and evolving treatment
strategies across the care
journey.
We work alongside you through
case discussions, scientific
support, and ongoing
engagement — not just a report
delivery service.
Discover how 1Cell.Ai fits into your clinical workflow. Explore our products and the technology powering precision diagnostics.